Airway Obstruction Is Common but Unsuspected in Patients Admitted to a General Medicine Service

Chest

Volumn 125, Issue 1, 2004, Pages 106-111

  Zaas, David ^a   Wise, Robert ^a   Wiener, Charles ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway obstruction; COPD; FEV1; FVC; Obstructive lung disease; Spirometry

Indexed keywords

BRONCHODILATING AGENT;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL SERVICE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SPIROMETRY; TEACHING HOSPITAL; URBAN AREA;

EID: 1642534597     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.1.106     Document Type: Article

References (29)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152(5 pt 2):S77-S121
2. Hoyert DL, Kochanek KD, Murphy SL. Deaths: final data for 1997. Natl Vital Stat Rep 1999; 47:1-104
3. Benson V, Marano MA. Current estimates from the National Health Interview Survey, 1995. Vital Health Stat 10 1998; 1-428
4. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000; 117(Suppl):1S-4S
5. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1256-1276
6. Doherty DE. Early detection and management of COPD. Postgrad Med 2002; 111:41-44,49-50
7. Sin DD, Safinski T, Ng YC, et al. The impact of chronic obstructive pulmonary disease on work loss in the United States. Am J Respir Crit Care Med 2002; 165:704-707
8. Bang KM, Gergen PJ, Kramer R, et al. The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest 1993; 103:536-540
9. Beaty TH, Cohen BH, Newill CA, et al. Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol 1982; 116:102-113
10. Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1990; 11:555-569
11. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313:711-715
12. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease: results from 20 years of prospective observation. Am Rev Respir Dis 1983; 128:491-500
13. Schunemann HJ, Dorn J, Grant BJ, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118:656-664
14. Ferris BG Jr, Higgins IT, Higgins MW, et al. Chronic nonspecific respiratory disease, Berlin, New Hampshire, 1961-1967: a cross-sectional study. Am Rev Respir Dis 1971; 104:232-244
15. Mannino DM, Gagnon RC, Petty TL, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160:1683-1689
16. Mueller RE, Keble DL, Plummer J, et al. The prevalence of chronic bronchitis, chronic airway obstruction, and respiratory symptoms in a Colorado city. Am Rev Respir Dis 1971; 103:209-228
17. Petty TL. Strategies in preserving lung health and preventing COPD and associated diseases: the National Lung Health Education Program. Chest 1998; 113(Suppl):123S-163S
18. Webb WR. Radiology of obstructive pulmonary disease. AJR Am J Roentgenol 1997; 169:637-647
19. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
20. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of die general U.S. population. Am J Respir Grit Care Med 1999; 159:179-187
21. Pena VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118:981-989
22. Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J 1999; 13:1109-1114
23. Mannino DM. COPD: Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002; 121: 121S-126S
24. van den BG, Rutten-van Molken MP, Tirimanna PR, et al. Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme. Eur Respir J 1998; 11:67-72
25. Mannino DM, Etzel RA, Flanders WD. Do the medical history and physical examination predict low lung function? Arch Intern Med 1993; 153:1892-1897
26. Cigarette smoking among adults-United States, 1998. MMWR Morb Mortal Wkly Rep 2000; 49:881-884
27. Perez-Stable EJ, Marin G, Marin BV, et al. Misclassification of smoking status by self-reported cigarette consumption. Am Rev Respir Dis 1992; 145:53-57
28. O'Donnell DE. Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful? Chest 2000; 117(Suppl):42S-47S
29. Guell R, Casan P, Belda J, et al. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000; 117:976-983